tirzepatide and cancer risk Popular obesity medications significantly lower overall risk, study finds. The breakthrough class of obesity medications, including GLP-1 receptor agonists like semaglutide dual GLP-1/GIP receptor agonists like tirzepatide, continue to make Weight-loss jabs 'slash cancer risk

Studies show that irradiated pheomelanin generates significant superoxide radicals, while eumelanin produces none explaining why pale/red-haired individuals burn "from the inside out." 3

The most recent STEP UP trial data shows even more promising results with higher-dose semaglutide ^1

Semaglutide is an excellent option if youve struggled with traditional weight loss methods

1165 Foods rich in antioxidants such as vitamin C, vitamin E, and flavonoids in the diet aid in scavenging free radicals, reducing oxidative stress damage and thereby promoting mitochondrial energy production

Compared with DPP-4 inhibitor initiation, GLP-1 receptor agonist initiation was associated with a higher risk of incident psoriasis, hazard ratio 1.19 with a 95% confidence interval of 1.11 to 1.28, and lower risks of pemphigus, hazard ratio 0.32, and bullous pemphigoid, hazard ratio 0.61, over up to four years

Studies show larger amounts of weight loss with less side effects with tirzepatide over other drugs in its class